These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 30685832)

  • 1. Needs with Regard to Decision Support Systems for Treating Patients with Incurable Non-small Cell Lung Cancer.
    Révész D; Engelhardt EG; Tamminga JJ; Schramel FMNH; Onwuteaka-Philipsen BD; van de Garde EMW; Steyerberg EW; de Vet HCW; Coupé VMH
    J Cancer Educ; 2020 Apr; 35(2):345-351. PubMed ID: 30685832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision support systems for incurable non-small cell lung cancer: a systematic review.
    Révész D; Engelhardt EG; Tamminga JJ; Schramel FMNH; Onwuteaka-Philipsen BD; van de Garde EMW; Steyerberg EW; Jansma EP; De Vet HCW; Coupé VMH
    BMC Med Inform Decis Mak; 2017 Oct; 17(1):144. PubMed ID: 28969629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inventory of oncologists' unmet needs for tools to support decision-making about palliative treatment for metastatic colorectal cancer.
    Engelhardt EG; Révész D; Tamminga HJ; Punt CJA; Koopman M; Onwuteaka-Philipsen BD; Steyerberg EW; de Vet HCW; Coupé VMH
    BMC Med Inform Decis Mak; 2018 Dec; 18(1):132. PubMed ID: 30551735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-Line Treatment Selection in Patients With Non-Small-Cell Lung Cancer of Adenocarcinoma Histology: Findings From a European Survey of Treating Physicians.
    Girard N; Corral J; Cortinovis D; Heigener DF
    Clin Lung Cancer; 2017 Mar; 18(2):e89-e97. PubMed ID: 27865625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical decision support needs assessment of community-based physicians.
    Richardson JE; Ash JS
    J Am Med Inform Assoc; 2011 Dec; 18 Suppl 1(Suppl 1):i28-35. PubMed ID: 21890874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung cancer treatment in New Zealand: physician's attitudes.
    Christmas T; Findlay M
    N Z Med J; 2004 Jun; 117(1196):U931. PubMed ID: 15280935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferences of patients with advanced lung cancer regarding the involvement of family and others in medical decision-making.
    Pardon K; Deschepper R; Stichele RV; Bernheim JL; Mortier F; Bossuyt N; Schallier D; Germonpré P; Galdermans D; Van Kerckhoven W; Deliens L;
    J Palliat Med; 2010 Oct; 13(10):1199-203. PubMed ID: 20849278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.
    J Clin Oncol; 1997 Aug; 15(8):2996-3018. PubMed ID: 9256144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.
    Califano R; Karamouzis MV; Banerjee S; de Azambuja E; Guarneri V; Hutka M; Jordan K; Kamposioras K; Martinelli E; Corral J; Postel-Vinay S; Preusser M; Porcu L; Torri V
    Lung Cancer; 2014 Jul; 85(1):74-80. PubMed ID: 24746176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real world study for the concordance between IBM Watson for Oncology and clinical practice in advanced non-small cell lung cancer patients at a lung cancer center in China.
    Yao S; Wang R; Qian K; Zhang Y
    Thorac Cancer; 2020 May; 11(5):1265-1270. PubMed ID: 32191394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage III Non-small Cell Lung Cancer: A UK National Survey of Practice.
    Evison M; Edwards J; McDonald F; Popat S
    Clin Oncol (R Coll Radiol); 2020 Aug; 32(8):527-536. PubMed ID: 32216979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digital Monitoring and Management of Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Treated With Cancer Immunotherapy and Its Impact on Quality of Clinical Care: Interview and Survey Study Among Health Care Professionals and Patients.
    Schmalz O; Jacob C; Ammann J; Liss B; Iivanainen S; Kammermann M; Koivunen J; Klein A; Popescu RA
    J Med Internet Res; 2020 Dec; 22(12):e18655. PubMed ID: 33346738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment selection of early stage non-small cell lung cancer: the role of the patient in clinical decision making.
    Mokhles S; Nuyttens JJME; de Mol M; Aerts JGJV; Maat APWM; Birim Ö; Bogers AJJC; Takkenberg JJM
    BMC Cancer; 2018 Jan; 18(1):79. PubMed ID: 29334910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a National Comprehensive Cancer Network Guidelines-Based Decision Support Tool in Patients With Non-Small Cell Lung Cancer: A Nonrandomized Clinical Trial.
    Wu SY; Lazar AA; Gubens MA; Blakely CM; Gottschalk AR; Jablons DM; Jahan TM; Wang VEH; Dunbar TL; Wong ML; Chan JW; Guthrie W; Belkora J; Yom SS
    JAMA Netw Open; 2020 Sep; 3(9):e209750. PubMed ID: 32997124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dumping the information bucket: A qualitative study of clinicians caring for patients with early stage non-small cell lung cancer.
    Golden SE; Thomas CR; Moghanaki D; Slatore CG;
    Patient Educ Couns; 2017 May; 100(5):861-870. PubMed ID: 28034611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Evaluation of a Real-World Outcomes-Based Tool to Support Informed Clinical Decision Making in the Palliative Treatment of Patients With Metastatic NSCLC.
    Cramer-van der Welle CM; Kastelijn EA; Plouvier BC; van Uden-Kraan CF; Schramel FMNH; Groen HJM; van de Garde EMW
    JCO Clin Cancer Inform; 2021 May; 5():570-578. PubMed ID: 34010031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Decision Drivers in Stage III Non-Small-Cell Lung Cancer: Outcomes of a Web-Based Survey of Oncologists in the United States.
    Cotarla I; Boron ML; Cullen SL; Spinner DS; Faulkner EC; Carroll MC; Shah S; Yagui-Beltran A
    JCO Oncol Pract; 2020 Oct; 16(10):e1232-e1242. PubMed ID: 32552457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of immunotherapy for survivors of stage IV non-small cell lung cancer: patient perspectives on quality of life.
    Park R; Shaw JW; Korn A; McAuliffe J
    J Cancer Surviv; 2020 Jun; 14(3):363-376. PubMed ID: 31950409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of non-small cell lung cancer, stage IV: ACCP evidence-based clinical practice guidelines (2nd edition).
    Socinski MA; Crowell R; Hensing TE; Langer CJ; Lilenbaum R; Sandler AB; Morris D;
    Chest; 2007 Sep; 132(3 Suppl):277S-289S. PubMed ID: 17873174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beliefs among pulmonologists and thoracic surgeons in the therapeutic approach to non-small cell lung cancer.
    Schroen AT; Detterbeck FC; Crawford R; Rivera MP; Socinski MA
    Chest; 2000 Jul; 118(1):129-37. PubMed ID: 10893370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.